{
  "id": "https://openalex.org/W2460495142",
  "doi": null,
  "title": "Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective.",
  "display_name": "Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective.",
  "publication_year": 2007,
  "publication_date": "2007-09-01",
  "ids": {
    "openalex": "https://openalex.org/W2460495142",
    "mag": "2460495142",
    "pmid": "https://pubmed.ncbi.nlm.nih.gov/17762902"
  },
  "language": "en",
  "primary_location": {
    "is_oa": false,
    "landing_page_url": "https://pubmed.ncbi.nlm.nih.gov/17762902",
    "pdf_url": null,
    "source": {
      "id": "https://openalex.org/S4306525036",
      "display_name": "PubMed",
      "issn_l": null,
      "issn": null,
      "is_oa": false,
      "is_in_doaj": false,
      "is_indexed_in_scopus": false,
      "is_core": false,
      "host_organization": "https://openalex.org/I1299303238",
      "host_organization_name": "National Institutes of Health",
      "host_organization_lineage": [
        "https://openalex.org/I1299303238"
      ],
      "host_organization_lineage_names": [
        "National Institutes of Health"
      ],
      "type": "repository"
    },
    "license": null,
    "license_id": null,
    "version": null,
    "is_accepted": false,
    "is_published": false
  },
  "type": "article",
  "type_crossref": "journal-article",
  "indexed_in": [
    "pubmed"
  ],
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "authorships": [
    {
      "author_position": "first",
      "author": {
        "id": "https://openalex.org/A5002599922",
        "display_name": "Mario E. Lacouture",
        "orcid": "https://orcid.org/0000-0002-4818-3710"
      },
      "institutions": [
        {
          "id": "https://openalex.org/I111979921",
          "display_name": "Northwestern University",
          "ror": "https://ror.org/000e0be47",
          "country_code": "US",
          "type": "funder",
          "lineage": [
            "https://openalex.org/I111979921"
          ]
        }
      ],
      "countries": [
        "US"
      ],
      "is_corresponding": false,
      "raw_author_name": "M E Lacouture",
      "raw_affiliation_strings": [
        "SERIES Clinic, Department of Dermatology and Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA."
      ],
      "affiliations": [
        {
          "raw_affiliation_string": "SERIES Clinic, Department of Dermatology and Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.",
          "institution_ids": [
            "https://openalex.org/I111979921"
          ]
        }
      ]
    },
    {
      "author_position": "last",
      "author": {
        "id": "https://openalex.org/A5047007478",
        "display_name": "B. Melosky",
        "orcid": null
      },
      "institutions": [],
      "countries": [],
      "is_corresponding": false,
      "raw_author_name": "B L Melosky",
      "raw_affiliation_strings": [],
      "affiliations": []
    }
  ],
  "institution_assertions": [],
  "countries_distinct_count": 1,
  "institutions_distinct_count": 1,
  "corresponding_author_ids": [],
  "corresponding_institution_ids": [],
  "apc_list": null,
  "apc_paid": null,
  "fwci": 3.764,
  "has_fulltext": false,
  "cited_by_count": 81,
  "citation_normalized_percentile": {
    "value": 0.867432,
    "is_in_top_1_percent": false,
    "is_in_top_10_percent": false
  },
  "cited_by_percentile_year": {
    "min": 96,
    "max": 97
  },
  "biblio": {
    "volume": "12",
    "issue": "6",
    "first_page": "1",
    "last_page": "5"
  },
  "is_retracted": false,
  "is_paratext": false,
  "primary_topic": {
    "id": "https://openalex.org/T11157",
    "display_name": "Chronic Lymphocytic Leukemia Research",
    "score": 0.9991,
    "subfield": {
      "id": "https://openalex.org/subfields/2716",
      "display_name": "Genetics"
    },
    "field": {
      "id": "https://openalex.org/fields/27",
      "display_name": "Medicine"
    },
    "domain": {
      "id": "https://openalex.org/domains/4",
      "display_name": "Health Sciences"
    }
  },
  "topics": [
    {
      "id": "https://openalex.org/T11157",
      "display_name": "Chronic Lymphocytic Leukemia Research",
      "score": 0.9991,
      "subfield": {
        "id": "https://openalex.org/subfields/2716",
        "display_name": "Genetics"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T10755",
      "display_name": "HER2/EGFR in Cancer Research",
      "score": 0.9989,
      "subfield": {
        "id": "https://openalex.org/subfields/2730",
        "display_name": "Oncology"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    },
    {
      "id": "https://openalex.org/T10185",
      "display_name": "Lymphoma Diagnosis and Treatment",
      "score": 0.9979,
      "subfield": {
        "id": "https://openalex.org/subfields/2734",
        "display_name": "Pathology and Forensic Medicine"
      },
      "field": {
        "id": "https://openalex.org/fields/27",
        "display_name": "Medicine"
      },
      "domain": {
        "id": "https://openalex.org/domains/4",
        "display_name": "Health Sciences"
      }
    }
  ],
  "keywords": [
    {
      "id": "https://openalex.org/keywords/panitumumab",
      "display_name": "Panitumumab",
      "score": 0.8003986
    },
    {
      "id": "https://openalex.org/keywords/egfr-inhibitors",
      "display_name": "EGFR Inhibitors",
      "score": 0.43665394
    }
  ],
  "concepts": [
    {
      "id": "https://openalex.org/C2779998722",
      "wikidata": "https://www.wikidata.org/wiki/Q420296",
      "display_name": "Cetuximab",
      "level": 4,
      "score": 0.9575007
    },
    {
      "id": "https://openalex.org/C71924100",
      "wikidata": "https://www.wikidata.org/wiki/Q11190",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.86148214
    },
    {
      "id": "https://openalex.org/C2778087573",
      "wikidata": "https://www.wikidata.org/wiki/Q418369",
      "display_name": "Erlotinib",
      "level": 4,
      "score": 0.8234308
    },
    {
      "id": "https://openalex.org/C2778332735",
      "wikidata": "https://www.wikidata.org/wiki/Q417775",
      "display_name": "Panitumumab",
      "level": 5,
      "score": 0.8003986
    },
    {
      "id": "https://openalex.org/C2779438470",
      "wikidata": "https://www.wikidata.org/wiki/Q424401",
      "display_name": "Epidermal growth factor receptor",
      "level": 3,
      "score": 0.6384646
    },
    {
      "id": "https://openalex.org/C143998085",
      "wikidata": "https://www.wikidata.org/wiki/Q162555",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.53803873
    },
    {
      "id": "https://openalex.org/C526805850",
      "wikidata": "https://www.wikidata.org/wiki/Q188874",
      "display_name": "Colorectal cancer",
      "level": 3,
      "score": 0.52159965
    },
    {
      "id": "https://openalex.org/C126322002",
      "wikidata": "https://www.wikidata.org/wiki/Q11180",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.5124591
    },
    {
      "id": "https://openalex.org/C2780580887",
      "wikidata": "https://www.wikidata.org/wiki/Q417824",
      "display_name": "Gefitinib",
      "level": 4,
      "score": 0.4730498
    },
    {
      "id": "https://openalex.org/C2776833033",
      "wikidata": "https://www.wikidata.org/wiki/Q1783924",
      "display_name": "Head and neck squamous-cell carcinoma",
      "level": 4,
      "score": 0.44032001
    },
    {
      "id": "https://openalex.org/C2777506169",
      "wikidata": "https://www.wikidata.org/wiki/Q424401",
      "display_name": "EGFR inhibitors",
      "level": 4,
      "score": 0.43665394
    },
    {
      "id": "https://openalex.org/C2780210213",
      "wikidata": "https://www.wikidata.org/wiki/Q212961",
      "display_name": "Pancreatic cancer",
      "level": 3,
      "score": 0.42698577
    },
    {
      "id": "https://openalex.org/C535046627",
      "wikidata": "https://www.wikidata.org/wiki/Q30612",
      "display_name": "Clinical trial",
      "level": 2,
      "score": 0.41749343
    },
    {
      "id": "https://openalex.org/C2776530083",
      "wikidata": "https://www.wikidata.org/wiki/Q1783924",
      "display_name": "Head and neck cancer",
      "level": 3,
      "score": 0.36952502
    },
    {
      "id": "https://openalex.org/C98274493",
      "wikidata": "https://www.wikidata.org/wiki/Q128406",
      "display_name": "Pharmacology",
      "level": 1,
      "score": 0.3561628
    },
    {
      "id": "https://openalex.org/C121608353",
      "wikidata": "https://www.wikidata.org/wiki/Q12078",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.34172106
    }
  ],
  "mesh": [
    {
      "descriptor_ui": "D000970",
      "descriptor_name": "Antineoplastic Agents",
      "qualifier_ui": "Q000009",
      "qualifier_name": "adverse effects",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D003875",
      "descriptor_name": "Drug Eruptions",
      "qualifier_ui": "Q000209",
      "qualifier_name": "etiology",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D003875",
      "descriptor_name": "Drug Eruptions",
      "qualifier_ui": "Q000628",
      "qualifier_name": "therapy",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D066246",
      "descriptor_name": "ErbB Receptors",
      "qualifier_ui": "Q000037",
      "qualifier_name": "antagonists & inhibitors",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D047428",
      "descriptor_name": "Protein Kinase Inhibitors",
      "qualifier_ui": "Q000009",
      "qualifier_name": "adverse effects",
      "is_major_topic": true
    },
    {
      "descriptor_ui": "D000911",
      "descriptor_name": "Antibodies, Monoclonal",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000911",
      "descriptor_name": "Antibodies, Monoclonal",
      "qualifier_ui": "Q000009",
      "qualifier_name": "adverse effects",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D061067",
      "descriptor_name": "Antibodies, Monoclonal, Humanized",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000970",
      "descriptor_name": "Antineoplastic Agents",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000970",
      "descriptor_name": "Antineoplastic Agents",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000068818",
      "descriptor_name": "Cetuximab",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D003875",
      "descriptor_name": "Drug Eruptions",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D066246",
      "descriptor_name": "ErbB Receptors",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000069347",
      "descriptor_name": "Erlotinib Hydrochloride",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000077156",
      "descriptor_name": "Gefitinib",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D006801",
      "descriptor_name": "Humans",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009369",
      "descriptor_name": "Neoplasms",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D009369",
      "descriptor_name": "Neoplasms",
      "qualifier_ui": "Q000188",
      "qualifier_name": "drug therapy",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D000077544",
      "descriptor_name": "Panitumumab",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D047428",
      "descriptor_name": "Protein Kinase Inhibitors",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D047428",
      "descriptor_name": "Protein Kinase Inhibitors",
      "qualifier_ui": "Q000627",
      "qualifier_name": "therapeutic use",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D011799",
      "descriptor_name": "Quinazolines",
      "qualifier_ui": "Q000009",
      "qualifier_name": "adverse effects",
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D012720",
      "descriptor_name": "Severity of Illness Index",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D012867",
      "descriptor_name": "Skin",
      "qualifier_ui": "",
      "qualifier_name": null,
      "is_major_topic": false
    },
    {
      "descriptor_ui": "D012867",
      "descriptor_name": "Skin",
      "qualifier_ui": "Q000473",
      "qualifier_name": "pathology",
      "is_major_topic": false
    }
  ],
  "locations_count": 1,
  "locations": [
    {
      "is_oa": false,
      "landing_page_url": "https://pubmed.ncbi.nlm.nih.gov/17762902",
      "pdf_url": null,
      "source": {
        "id": "https://openalex.org/S4306525036",
        "display_name": "PubMed",
        "issn_l": null,
        "issn": null,
        "is_oa": false,
        "is_in_doaj": false,
        "is_indexed_in_scopus": false,
        "is_core": false,
        "host_organization": "https://openalex.org/I1299303238",
        "host_organization_name": "National Institutes of Health",
        "host_organization_lineage": [
          "https://openalex.org/I1299303238"
        ],
        "host_organization_lineage_names": [
          "National Institutes of Health"
        ],
        "type": "repository"
      },
      "license": null,
      "license_id": null,
      "version": null,
      "is_accepted": false,
      "is_published": false
    }
  ],
  "best_oa_location": null,
  "sustainable_development_goals": [
    {
      "display_name": "Good health and well-being",
      "id": "https://metadata.un.org/sdg/3",
      "score": 0.82
    }
  ],
  "grants": [],
  "datasets": [],
  "versions": [],
  "referenced_works_count": 23,
  "referenced_works": [
    "https://openalex.org/W1579956540",
    "https://openalex.org/W1976877888",
    "https://openalex.org/W1993067667",
    "https://openalex.org/W1996410758",
    "https://openalex.org/W2008131591",
    "https://openalex.org/W2011578371",
    "https://openalex.org/W2014580374",
    "https://openalex.org/W2018868936",
    "https://openalex.org/W2021455866",
    "https://openalex.org/W2024644107",
    "https://openalex.org/W2029435743",
    "https://openalex.org/W2043228997",
    "https://openalex.org/W2072882391",
    "https://openalex.org/W2085251775",
    "https://openalex.org/W2088574571",
    "https://openalex.org/W2094487424",
    "https://openalex.org/W2121770885",
    "https://openalex.org/W2124232223",
    "https://openalex.org/W2139254223",
    "https://openalex.org/W2141370216",
    "https://openalex.org/W2142014464",
    "https://openalex.org/W2159619274",
    "https://openalex.org/W2162283821"
  ],
  "related_works": [
    "https://openalex.org/W2168377135",
    "https://openalex.org/W2163592822",
    "https://openalex.org/W2160344439",
    "https://openalex.org/W2144648936",
    "https://openalex.org/W2138297714",
    "https://openalex.org/W2121275619",
    "https://openalex.org/W2106789440",
    "https://openalex.org/W2100842180",
    "https://openalex.org/W2090359261",
    "https://openalex.org/W2077950012",
    "https://openalex.org/W2058992264",
    "https://openalex.org/W2039979010",
    "https://openalex.org/W2031520822",
    "https://openalex.org/W2011513069",
    "https://openalex.org/W1998085563",
    "https://openalex.org/W1991915991",
    "https://openalex.org/W1975426795",
    "https://openalex.org/W1973060721",
    "https://openalex.org/W1968151389",
    "https://openalex.org/W1959598232"
  ],
  "abstract_inverted_index": {
    "The": [
      0,
      168
    ],
    "epidermal": [
      1
    ],
    "growth": [
      2,
      94
    ],
    "factor": [
      3
    ],
    "receptor": [
      4
    ],
    "(EGFR)": [
      5
    ],
    "is": [
      6,
      78,
      155,
      176,
      191
    ],
    "often": [
      7
    ],
    "overexpressed": [
      8
    ],
    "or": [
      9
    ],
    "dysregulated": [
      10
    ],
    "in": [
      11,
      23,
      121,
      129,
      158
    ],
    "solid": [
      12,
      85
    ],
    "tumors.": [
      13
    ],
    "Targeting": [
      14
    ],
    "the": [
      15,
      24,
      41,
      100,
      107,
      122,
      147,
      159,
      200,
      227
    ],
    "EGFR-mediated": [
      16
    ],
    "signaling": [
      17
    ],
    "pathway": [
      18,
      92
    ],
    "has": [
      19,
      117
    ],
    "become": [
      20
    ],
    "routine": [
      21
    ],
    "practice": [
      22
    ],
    "treatment": [
      25,
      108,
      198
    ],
    "of": [
      26,
      109,
      174,
      194,
      199,
      206
    ],
    "lung,": [
      27
    ],
    "pancreatic,": [
      28
    ],
    "head": [
      29,
      162
    ],
    "and": [
      30,
      32,
      60,
      72,
      95,
      99,
      137,
      163,
      186,
      212,
      218
    ],
    "neck,": [
      31
    ],
    "colon": [
      33
    ],
    "carcinomas.": [
      34
    ],
    "Available": [
      35
    ],
    "agents": [
      36
    ],
    "with": [
      37,
      131,
      178
    ],
    "selected": [
      38
    ],
    "activity": [
      39
    ],
    "towards": [
      40
    ],
    "EGFR": [
      42
    ],
    "include": [
      43
    ],
    "low": [
      44
    ],
    "molecular": [
      45
    ],
    "weight": [
      46
    ],
    "tyrosine": [
      47
    ],
    "kinase": [
      48
    ],
    "inhibitors,": [
      49
    ],
    "e.g.,": [
      50
    ],
    "erlotinib": [
      51,
      105
    ],
    "(Tarceva,": [
      52
    ],
    "Genentech": [
      53
    ],
    "BioOncology/": [
      54
    ],
    "OSI": [
      55
    ],
    "Pharmaceuticals/": [
      56
    ],
    "F.": [
      57
    ],
    "Hoffmann-La": [
      58
    ],
    "Roche)": [
      59
    ],
    "monoclonal": [
      61
    ],
    "antibodies,": [
      62
    ],
    "such": [
      63
    ],
    "as": [
      64
    ],
    "cetuximab": [
      65
    ],
    "(Erbitux,": [
      66
    ],
    "Bristol-Myers": [
      67
    ],
    "Squibb/": [
      68
    ],
    "ImClone": [
      69
    ],
    "Systems/": [
      70
    ],
    "Merck)": [
      71
    ],
    "panitumumab": [
      73,
      140
    ],
    "(Vectibix,": [
      74,
      141
    ],
    "Amgen).": [
      75
    ],
    "Their": [
      76
    ],
    "use": [
      77,
      125
    ],
    "anticipated": [
      79
    ],
    "to": [
      80
    ],
    "increase": [
      81
    ],
    "for": [
      82,
      93,
      106,
      124,
      150,
      161,
      171
    ],
    "treating": [
      83
    ],
    "other": [
      84
    ],
    "tumors": [
      86
    ],
    "that": [
      87
    ],
    "are": [
      88
    ],
    "dependent": [
      89
    ],
    "on": [
      90
    ],
    "this": [
      91,
      172
    ],
    "proliferation.": [
      96
    ],
    "Health": [
      97
    ],
    "Canada": [
      98
    ],
    "US": [
      101,
      123,
      148,
      160
    ],
    "FDA": [
      102,
      149
    ],
    "have": [
      103,
      208
    ],
    "approved": [
      104,
      120,
      145,
      157
    ],
    "advanced": [
      110
    ],
    "non-small": [
      111
    ],
    "cell": [
      112,
      166
    ],
    "lung": [
      113
    ],
    "carcinoma": [
      114
    ],
    "(NSCLC).": [
      115
    ],
    "It": [
      116
    ],
    "also": [
      118,
      156
    ],
    "been": [
      119,
      209
    ],
    "against": [
      126
    ],
    "pancreatic": [
      127
    ],
    "cancer": [
      128
    ],
    "combination": [
      130
    ],
    "gemcitabine": [
      132
    ],
    "(Gemzar,": [
      133
    ],
    "Eli": [
      134
    ],
    "Lilly).": [
      135
    ],
    "Cetuximab": [
      136,
      154
    ],
    "most": [
      138
    ],
    "recently": [
      139
    ],
    "Amgen/": [
      142
    ],
    "Abgenix)": [
      143
    ],
    "were": [
      144
    ],
    "by": [
      146
    ],
    "metastatic": [
      151
    ],
    "colorectal": [
      152
    ],
    "carcinoma.": [
      153,
      167
    ],
    "neck": [
      164
    ],
    "squamous": [
      165
    ],
    "safety": [
      169
    ],
    "profile": [
      170
    ],
    "class": [
      173
    ],
    "drugs": [
      175
    ],
    "unique,": [
      177
    ],
    "virtually": [
      179
    ],
    "no": [
      180
    ],
    "hematological": [
      181
    ],
    "toxicity,": [
      182
    ],
    "but": [
      183
    ],
    "frequent": [
      184
    ],
    "cutaneous": [
      185
    ],
    "gastrointestinal": [
      187
    ],
    "side-effects.": [
      188
    ],
    "Although": [
      189
    ],
    "there": [
      190
    ],
    "a": [
      192
    ],
    "dearth": [
      193
    ],
    "randomized": [
      195
    ],
    "trials": [
      196
    ],
    "addressing": [
      197
    ],
    "dermatological": [
      201
    ],
    "side-effects,": [
      202
    ],
    "some": [
      203
    ],
    "basic": [
      204
    ],
    "principles": [
      205
    ],
    "management": [
      207
    ],
    "agreed": [
      210
    ],
    "upon": [
      211
    ],
    "can": [
      213
    ],
    "likely": [
      214
    ],
    "improve": [
      215
    ],
    "patient": [
      216
    ],
    "compliance": [
      217
    ],
    "decrease": [
      219
    ],
    "inappropriate": [
      220
    ],
    "dose": [
      221
    ],
    "reduction,": [
      222
    ],
    "which": [
      223
    ],
    "may": [
      224
    ],
    "negatively": [
      225
    ],
    "influence": [
      226
    ],
    "antitumor": [
      228
    ],
    "effect.": [
      229
    ]
  },
  "abstract_inverted_index_v3": null,
  "cited_by_api_url": "https://api.openalex.org/works?filter=cites:W2460495142",
  "counts_by_year": [
    {
      "year": 2024,
      "cited_by_count": 2
    },
    {
      "year": 2023,
      "cited_by_count": 2
    },
    {
      "year": 2022,
      "cited_by_count": 1
    },
    {
      "year": 2020,
      "cited_by_count": 1
    },
    {
      "year": 2019,
      "cited_by_count": 2
    },
    {
      "year": 2018,
      "cited_by_count": 4
    },
    {
      "year": 2016,
      "cited_by_count": 3
    },
    {
      "year": 2015,
      "cited_by_count": 4
    },
    {
      "year": 2014,
      "cited_by_count": 9
    },
    {
      "year": 2013,
      "cited_by_count": 12
    },
    {
      "year": 2012,
      "cited_by_count": 4
    }
  ],
  "updated_date": "2025-05-16T22:57:38.399237",
  "created_date": "2016-07-22"
}